US5147661046
© Globe Newswire
17.12.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
News Preview
Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product...
Themefolio
Profiler
Peergroup
© BusinessWire
07.12.2025
LFCR
LISTED
NASDAQ
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders.
If you currently own Lifecore stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to t...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate in Upcoming Investor Conferences
News Preview
CHASKA, Minn, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in two upcoming investor conferences. Details regarding Lifecore’s participation are as follows:...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
30.10.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025
News Preview
Webcast Scheduled for Thursday, November 6 at 4:30 p.m. Eastern Webcast Scheduled for Thursday, November 6 at 4:30 p.m. Eastern...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.10.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
News Preview
Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
LFCR
LISTED
NASDAQ
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
News Preview
CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract development and manufacturing, today announced the sig...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
News Preview
CHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at three upcoming industry events. Details of the company’s activities at these events are as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
LFCR
LISTED
NASDAQ
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September 22, 2025, the Lifecore compensation committee approved the grant under Lifecore’s Equity Inducement Plan, as amended (the “Induce...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
News Preview
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual Contract Pharma Contracting and Outsourcing Conference. Recognized as one of the top annual e...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate in Upcoming Investor Conferences
News Preview
CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore’s participation are as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.07.2025
LFCR
LISTED
NASDAQ
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on July 11, 2025, the Lifecore compensation committee approved grants under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
News Preview
Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
12.06.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
News Preview
Fortifies Balance Sheet and Reinforces Disciplined Capital Management Approach Fortifies Balance Sheet and Reinforces Disciplined Capital Management Approach...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
News Preview
Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.04.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
News Preview
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO Live 2025 conference. Billed as a premiere partnering event for the biopharma outsourcing i...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.04.2025
LFCR
LISTED
NASDAQ
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stoc...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.04.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
News Preview
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
News Preview
-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers --...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.03.2025
LFCR
LISTED
NASDAQ
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
News Preview
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.02.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
News Preview
CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 2025 BIO CEO & Investor Conference. The conference will take place February 10-11, 2025, in New York,...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.01.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Announces Special Stockholder Meeting
News Preview
Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock Terms Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred St...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.01.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
News Preview
Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
News Preview
CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take place January 13-16, 2025, in San...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.01.2025
LFCR
LISTED
NASDAQ
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
News Preview
-- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers --...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
News Preview
Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
News Preview
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
News Preview
Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.11.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Hosts Virtual Investor Day
News Preview
CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it hosted a virtual investor day prior to market open during which Lifecore’s senior management team discussed the company’s business and stra...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
News Preview
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will host a virtual investor day on Thursday, November 21, 2024, prior to market open. The event will take place from 8:00 – 9:30 a.m. East...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.11.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
News Preview
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.10.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
News Preview
-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers --...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.10.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
News Preview
PIPE with New and Existing Investors Supports Working Capital and Operations PIPE with New and Existing Investors Supports Working Capital and Operations...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
News Preview
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the first quarter of fiscal year 2025 on Friday, October 4, 2024, prior to market open and will host a we...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
News Preview
Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO...
Themefolio
Profiler
Peergroup
© BusinessWire
27.09.2024
LFCR
LISTED
NASDAQ
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) (NASDAQ: LFCR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissio...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2024
LFCR
LISTED
NASDAQ
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 27, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) securities between October 7, 2020 and March 19, 2024, inclusive (the “Class Period”).
I...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
News Preview
CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at four upcoming industry events. Details of the company’s activities at these events are as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
News Preview
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
News Preview
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the Company’s president and chief executive officer, and Ryan Lake, the Company’s chief financial officer, wil...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
News Preview
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received written notice from the Nasdaq Listing Qualifications Department stating that the Company has regained compl...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
News Preview
Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore has granted a restricted stock unit (“RSU”) award with respect to 262,500 shares of its common stock and a performa...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
News Preview
CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the Company will participate in the upcoming 17th Annual Barrington Research Virtual Fall Investment Conference. Lifecore ma...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.08.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Announces Chief Financial Officer Transition
News Preview
Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
News Preview
-- Recorded Revenues of $128.3 million for Fiscal 2024; Year-Over-Year Increase of 24.2% ---- High Value Pipeline Continues to Advance Toward Commercialization ---- State-of-the-Art Technology Enhancements to Expand Capacityand New Business Opportunities –...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2024
LFCR
LISTED
NASDAQ
Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm
News Preview
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Minnesota on behalf of those who acquired Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) securities during the period of October 7, 2020 to March 19, 2024, inclusive (“the Class Per...
Themefolio
Profiler
Peergroup
© BusinessWire
12.08.2024
LFCR
LISTED
NASDAQ
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) (NASDAQ: LFCR) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for a...
Themefolio
Profiler
Peergroup
© BusinessWire
09.08.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit
News Preview
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Lifecore Biomedical, Inc. (NASDAQ: LFCR) securities between October 7, 2020 and March 19, 2024. Lifecore operates as an integrated contract development and manufacturing organization in the U.S. and inter...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.05.2024
LFCR
LISTED
NASDAQ
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CHASKA, Minn., May 22, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization, today announced that Lifecore has granted a restricted stock unit (“RSU”) award with respect to 525,000 shares of its common stock and a performance stock u...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.05.2024
LFCR
LISTED
NASDAQ
Lifecore Biomedical Completes Incremental Liquidity Initiatives
News Preview
Recent Initiatives Provide Approximately $8 Million of Non-Dilutive, Incremental Liquidity through Various Amendments with Lenders Recent Initiatives Provide Approximately $8 Million of Non-Dilutive, Incremental Liquidity through Various Amendments with Lenders...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
